Home
Deep Track Biotechnology Master Fund, 10% Owner: LB Pharmaceuticals LBRX Buy · Filed 25/09/16
Trade details
- Type
- Insider buy
- Amount
- $30,000,000
- Shares · price
- 2,000,000 sh · $15.00 a share
- Held after
- 2,686,138 sh
- Trade date
- 25/09/12
- Filed
- 25/09/16
- Days to filing
- 4 days
First buy since 2023
- Insiders buying this week
- 10 insiders
- Holding change
- +291.5%
LB Pharmaceuticals trades, last 26 weeks
What else happened in LB Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 25/08/13~25/10/12Deep Track Biotechnology Master Fund's recent trades
- Deep Track Biotechnology Master Fund
BuyLB Pharmaceuticals
BuyLB Pharmaceuticals
LBRX
$10M
666,666 sh
$10M
Filed 25/09/16
Traded 25/09/12
- Deep Track Biotechnology Master Fund
SellDynavax Technologies
SellDynavax Technologies
DVAX
$12.1M
1,094,994 sh
$12.1M
Filed 25/08/22
Traded 25/08/21
- Deep Track Biotechnology Master Fund
SellDynavax Technologies
SellDynavax Technologies
DVAX
$10.3M
970,143 sh
$10.3M
Filed 25/08/22
Traded 25/08/22
- Deep Track Biotechnology Master Fund
SellNektar Therapeutics
SellNektar Therapeutics
NKTR
$99.7K
56,000 sh
$99.7K
Filed 24/05/13
Traded 24/05/10
